Sign in
Taking people in United StatesNo phase

Colored light bulbs to ease pain in fibromyalgia and long-lasting muscle pain

Tests colored light against white light for pain in adults with fibromyalgia.

Key facts

Who runs it
University of North Carolina, Chapel Hill
Where
Chapel Hill, United StatesSee the site
Trial code
Registry title
Light Bulb Stimuli to Reduce Chronic Pain
Status
Recruiting
People taking part
40 people, planned
Started
9 Nov 2026
Expected to end
1 Jan 2028
Type of study
Interventional, 2 groups
Treatments tested
  • S-Cone Stimulating Chromatic Light
  • Equal-Energy White Light
Record updated
2 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with fibromyalgia or chronic widespread pain and fatigue. It tests whether colored light from home light bulbs lowers pain.

Age
18 years and older
Sex
All sexes
Disease stage
Fibromyalgia or chronic widespread pain and fatigue. Average pain ≥4 on a 0-10 scale over the past month. Pain for 3 months or longer, in 4 out of 5 body regions. Scores of ≥7 on the WPI and ≥5 on the SSS, or 4-6 on the WPI and ≥9 on the SSS (2016 Fibromyalgia Questionnaire).
Earlier treatment
People cannot join if changes to their pain treatment are expected in the next 3 months, such as surgery, new pain medicines, injections or pain procedures.

Main reasons for not taking part

  • Serious vision problems or blindness, color blindness, uveitis or cataracts
  • Pregnancy
  • Sensitivity to light or to mildly flickering light
  • History of seizures, or living with someone who has a history of seizures
  • Being in prison

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Adults ≥ 18 years of age
  • Individuals who have been diagnosed with fibromyalgia or suffer from chronic widespread pain and fatigue
  • An average pain severity ≥4 on the 0-10 NRS over the month prior to enrollment
  • Pain symptoms present for 3 months or longer
  • Pain must be present in 4 out of 5 body regions
  • A score of ≥7 on the Widespread pain index (WPI) and ≥5 on the symptom severity scale (SSS), or 4-6 on the WPI and ≥9 on the SSS in the 2016 Fibromyalgia Questionnaire
  • Willingness to adjust light levels in home environment so that the illumination (measured in lux) provided by the light bulbs is twice the ambient room illumination (also measured in lux)
  • Willingness to use study lightbulbs for 2 consecutive hours a day for 7 consecutive days according to study specifications for both conditions (total of 14 days using lightbulbs)
  • Alert and oriented, and able to provide informed consent
  • Ability to read and speak English to complete validated questionnaires

Who cannot take part

  • Analgesic treatment plan changes anticipated in the next 3 months (surgery, analgesic medication changes, injections, pain procedures, etc.)
  • Vision disorders or conditions resulting in severe vision impairment or blindness
  • History of photosensitivity or sensitivity to scintillating (mildly flickering) light
  • History of seizure disorder
  • Individuals living in households with people who have a history of seizure disorders
  • Other history or condition that would, in the investigator's judgment, indicate that the individual would highly likely be non-compliant with the study or unsuitable for the study
  • Individuals with self-report of color blindness, uveitis or cataracts
  • Prisoner Status
  • Pregnancy

Where in United States

  • University of North Carolina at Chapel HillChapel Hill, United StatesContact: Matt Mauck, MD, PhDTaking people

About the trial

What the trial wants to find out

This pilot randomized, double-blind, crossover clinical trial will evaluate the feasibility and preliminary efficacy of chromatic (colored) light exposure for reducing pain severity and pain sensitivity in adults with fibromyalgia or chronic widespread pain and fatigue. Participants will complete daily symptom surveys throughout the study and undergo patient-reported outcome assessments and quantitative sensory testing at multiple timepoints.

Read full original descriptionShow less

Participants will be randomized to receive either S-cone stimulating chromatic light or equal-energy white light for 2 hours daily over a 7-day treatment period. Following a 1-week washout, participants will cross over to the alternate condition. Outcomes will examine feasibility, changes in pain severity, pain interference, and measures of pain sensitivity. Total study duration is approximately 35 days.

The 2 groups in the trial

  • S-cone stimulating chromatic light first followed by equal-energy white lightTreatment being tested

    Participants randomized to this sequence will receive S-cone stimulating chromatic light during the first treatment period, followed by equal-energy white (flickering along the L/M axis) light during the second treatment period. Each treatment period consists of 2 hours of daily light exposure for 7 consecutive days, ideally between 5:00 a.m. and 10:00 a.m., delivered using programmed "TUO" light bulbs. The two treatment periods are separated by a 1-week washout period. Participants complete daily symptom surveys, patient-reported outcome measures, and quantitative sensory testing throughout the study.

    Treatment: S-Cone Stimulating Chromatic Light and Equal-Energy White Light

  • Equal-energy white light first followed by S-cone stimulating chromatic lightTreatment being tested

    Participants randomized to this sequence will receive equal-energy white light (flickering along the L/M axis) during the first treatment period, followed by S-cone stimulating chromatic light during the second treatment period. Each treatment period consists of 2 hours of daily light exposure for 7 consecutive days, ideally between 5:00 a.m. and 10:00 a.m., delivered using programmed "TUO" light bulbs. The two treatment periods are separated by a 1-week washout period. Participants complete daily symptom surveys, patient-reported outcome measures, and quantitative sensory testing throughout the study.

    Treatment: S-Cone Stimulating Chromatic Light and Equal-Energy White Light

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Chromatic Retinal Stimulation to Reduce Chronic Pain and Pain Sensitivity Using Light Bulbs: A Pilot Randomized Crossover Trial
Plain-language title
Colored light bulbs to ease pain in fibromyalgia and long-lasting muscle painGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
2 November 2026